Habuchi O, Tsuzuki M, Takeuchi I, Hara M, Matsui Y, Ashikari S
Department of Chemistry, Aichi Kyoiku University, Kariya, Japan.
Biochim Biophys Acta. 1991 Dec 3;1133(1):9-16. doi: 10.1016/0167-4889(91)90235-p.
We found that chondroitin 6-sulfotransferase and chondroitin 4-sulfotransferase were released into the culture medium from the cultured chick embryo chondrocytes. Since the release of the sulfotransferases was observed not only in serum-supplemented medium but also in serum-free medium, the released sulfotransferases were unlikely to be derived from serum. Addition of ascorbate to the serum-free medium supported the continuous release of the sulfotransferases. Monensin, which is known to cause dilatation of the Golgi apparatus and to inhibit sulfation of proteoglycan, was found to affect the release of the sulfotransferases. In the presence of 10(-6) M monensin, chondroitin 6-sulfotransferase activity in the cell layer was decreased to less than one tenth of the control, and the rate of the release of the activity became much smaller than the control after the initial rapid release. The activity of chondroitin 4-sulfotransferase was also affected by monensin, but the reduction of the chondroitin 4-sulfotransferase activity in the cell layer was not so great as the reduction of chondroitin 6-sulfotransferase activity. Unlike to the microsomal sulfotransferases, both chondroitin 6-sulfotransferase and chondroitin 4-sulfotransferase released into the culture medium were retained in the soluble fraction after centrifugation at 100,000 x g for 60 min, and were not activated by detergent. pH optimum and requirements for sulfhydryl compounds of the released sulfotransferases were similar to those observed previously in the chondroitin sulfotransferases from chick embryo cartilage and from cultured chick embryo chondrocytes. These results suggest that chondroitin sulfotransferases, which are localized in the Golgi apparatus, may be secreted to the extracellular space in a soluble form under the culture conditions.
我们发现,硫酸软骨素6 - 磺基转移酶和硫酸软骨素4 - 磺基转移酶从培养的鸡胚软骨细胞释放到培养基中。由于不仅在补充血清的培养基中观察到了磺基转移酶的释放,在无血清培养基中也观察到了,所以释放的磺基转移酶不太可能来源于血清。在无血清培养基中添加抗坏血酸能支持磺基转移酶的持续释放。莫能菌素已知会导致高尔基体扩张并抑制蛋白聚糖的硫酸化,发现它会影响磺基转移酶的释放。在存在10⁻⁶ M莫能菌素的情况下,细胞层中硫酸软骨素6 - 磺基转移酶的活性降低至对照的十分之一以下,并且在最初的快速释放后,该活性的释放速率变得比对照小得多。硫酸软骨素4 - 磺基转移酶的活性也受到莫能菌素的影响,但细胞层中硫酸软骨素4 - 磺基转移酶活性的降低不如硫酸软骨素6 - 磺基转移酶活性的降低那么大。与微粒体磺基转移酶不同,释放到培养基中的硫酸软骨素6 - 磺基转移酶和硫酸软骨素4 - 磺基转移酶在100,000×g离心60分钟后保留在可溶性部分中,并且不会被去污剂激活。释放的磺基转移酶的最适pH和对巯基化合物的需求与先前在鸡胚软骨和培养的鸡胚软骨细胞中的硫酸软骨素磺基转移酶中观察到的相似。这些结果表明,定位于高尔基体的硫酸软骨素磺基转移酶在培养条件下可能以可溶性形式分泌到细胞外空间。